BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11479211)

  • 1. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line.
    Liu G; Bode A; Ma WY; Sang S; Ho CT; Dong Z
    Cancer Res; 2001 Aug; 61(15):5749-56. PubMed ID: 11479211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.).
    Wang SY; Feng R; Lu Y; Bowman L; Ding M
    J Agric Food Chem; 2005 May; 53(10):4187-93. PubMed ID: 15884858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
    Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells.
    Liu G; Bibus DM; Bode AM; Ma WY; Holman RT; Dong Z
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7510-5. PubMed ID: 11416221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
    Li J; Ma C; Huang Y; Luo J; Huang C
    Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.
    Dong Z; Ma W; Huang C; Yang CS
    Cancer Res; 1997 Oct; 57(19):4414-9. PubMed ID: 9331105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element.
    Li JJ; Dong Z; Dawson MI; Colburn NH
    Cancer Res; 1996 Feb; 56(3):483-9. PubMed ID: 8564958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol.
    Bode AM; Ma WY; Surh YJ; Dong Z
    Cancer Res; 2001 Feb; 61(3):850-3. PubMed ID: 11221868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer.
    Dong Z; Huang C; Ma WY
    Anticancer Res; 1999; 19(5A):3743-7. PubMed ID: 10625951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.
    Khanal P; Choi HK; Namgoong GM; Ahn SG; Yoon JH; Sohn H; Choi HS
    Mol Carcinog; 2011 Dec; 50(12):961-71. PubMed ID: 21400615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS; Kim SH; Song YS; Surh YJ
    Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-specific activation of activator protein-1 in transgenic mice by 12-o-tetradecanoylphorbol-13-acetate with different administration methods.
    Zhong S; Quealy JA; Bode AM; Nomura M; Kaji A; Ma WY; Dong Z
    Cancer Res; 2001 May; 61(10):4084-91. PubMed ID: 11358830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of epidermal growth factor-induced cell transformation by tannins.
    Nomura M; Tsukada H; Ichimatsu D; Ito H; Yoshida T; Miyamoto K
    Phytochemistry; 2005 Sep; 66(17):2038-46. PubMed ID: 16153407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
    Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
    Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory and potential cancer chemopreventive constituents of the fruits of Morinda citrifolia (Noni).
    Akihisa T; Matsumoto K; Tokuda H; Yasukawa K; Seino K; Nakamoto K; Kuninaga H; Suzuki T; Kimura Y
    J Nat Prod; 2007 May; 70(5):754-7. PubMed ID: 17480098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway.
    Lin S; Li JJ; Fujii M; Hou DX
    Int J Oncol; 2003 Apr; 22(4):829-33. PubMed ID: 12632075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tetrandrine on epidermal growth factor-induced cell transformation and its signal transduction.
    Nomura M; Yamazaki R; Takaya M; Kikuchi M; Takahashi-Nishioka T; Akiyama K; Akiyama N; Moritani S; Kobayashi S
    Anticancer Res; 2007; 27(5A):3187-93. PubMed ID: 17970060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blackberry extracts inhibit activating protein 1 activation and cell transformation by perturbing the mitogenic signaling pathway.
    Feng R; Bowman LL; Lu Y; Leonard SS; Shi X; Jiang BH; Castranova V; Vallyathan V; Ding M
    Nutr Cancer; 2004; 50(1):80-9. PubMed ID: 15572301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.